| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
0.019 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |